Rasagiline
NDC 0093-3061, Rasagiline, tablet, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-3061
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021641
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3061 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RASAGILINE MESYLATE1 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-3061-56 | 00093306156 | 30 TABLET in 1 BOTTLE (0093-3061-56) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e802c83c-e581-4a11-b83d-1df47120078dNADAC price for package 00093306156
GET /v1/drugs/nadac/00093306156
Use it
Look up 0093-3061 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3061 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-3061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.